XTAI
1714
Market cap527mUSD
Jul 09, Last price
17.25TWD
1D
-2.82%
1Q
69.12%
Jan 2017
115.36%
Name
Ho Tung Chemical Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ho Tung Chemical Corp., established in New Taipei City, Taiwan, in 1980, operates as a comprehensive chemical enterprise. The company specializes in the research, production, marketing, and global distribution of a diverse array of chemical products, with a significant presence across Taiwan, China, Southeast Asia, and other international markets. Its core product portfolio encompasses a wide range of specialty chemicals. Key offerings include normal paraffin and various types of surfactants essential for industries like detergents and personal care. Specifically, it manufactures anionic surfactants such as linear alkylbenzene sulphonic acid (LABSA) and alcohol ether sulfates (e.g., sodium laureth sulphate); cationic surfactants like palmityl tri-methyl ammonium chloride, stearyl tri-methyl ammonium chloride, and alkyl dimethyl benzyl ammonium chloride; and non-ionic surfactants, including fatty alcohols, fatty alcohol ethoxylates, and coconut diethanol amide. Additionally, the company produces amphoteric surfactants such as cocamidopropyl betaine and dodecyl dimethyl betaine. Ho Tung also supplies de-aromatic solvents, which find application in diverse sectors including paints, coatings, consumer products, printing inks, and agricultural chemicals. Beyond its primary chemical manufacturing, Ho Tung diversifies its operations through various ventures. These include the trading and wholesale of oil, fuels, and other general commodities; the leasing of oil storage facilities; and the production and sale of cement, cement raw materials, and PMMA light guide plates. The company is also involved in the development of new energy solutions and advanced surfactants, alongside general investment activities.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||